Jovan Knutson News Today

NovoCure Limited (NASDAQ:NVCR) Q3 2023 Earnings Call Transcript October 26, 2023 NovoCure Limited beats earnings expectations. Reported EPS is $-0.46, expectations were $-0.52. Operator: Welcome to the NovoCure Q3 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your […]

NVCR earnings call for the period ending September 30, 2023.